Anixa Biosciences Inc

ANIX

$99M

Micro Cap

NASDAQPharmaceutical Preparations🇺🇸North AmericaSAN JOSE5 employees

Drugs in Pipeline

Phase 3 Programs

Upcoming Catalysts

Next Catalyst

Sep 9, 2026

Market Overview

Stock performance and key metrics

ANIX News

Catalyst Timeline

2 upcoming, 0 past

EarningsNext

ANIX Earnings Report

Sep 9, 2026Confirmed

EPS Est: $-0.08 | FQ end 2026-07

Conference

Sep 9, 2026AI-detected

Anixa Biosciences will present at the Nasdaq & LD Micro Inaugural SF Summit on September 9, 2026, highlighting clinical progress and collaborations with Cleveland Clinic and Moffitt Cancer Center.

Source

Drug Pipeline

No drugs found in this phase.

📑

Catalyst DossierPRO

The full research note — thesis, the if-approved scenario, financials & smart money. Compiled by CeliA.

→

Catalyst Verdict

Full breakdown — the signals behind the verdict

Market-Implied Move

Regulatory Approvals

Frequently asked questions

When is Anixa Biosciences Inc's next FDA catalyst?→

Anixa Biosciences Inc's (ANIX) next tracked catalyst is a Earnings expected September 9, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track ANIX biotech catalysts?→

Add ANIX to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Anixa Biosciences Inc's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply